¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"RE"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
  • JrId: 6889
    JournalTitle: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
    MedAbbr: Recent Results Cancer Res
    ISSN: 0080-0015
    ESSN:
    IsoAbbr: Recent Results Cancer Res.
    NlmId: 44671
  • JrId: 6890
    JournalTitle: Reconstruction surgery and traumatology.
    MedAbbr: Reconstr Surg Traumatol
    ISSN: 0080-0260
    ESSN:
    IsoAbbr:
    NlmId: 136516
  • JrId: 6891
    JournalTitle: the official journal of the Association of Rehabilitation Nurses.
    MedAbbr: Rehabil Nurs
    ISSN: 0278-4807
    ESSN:
    IsoAbbr:
    NlmId: 8104825
  • JrId: 6892
    JournalTitle: 1944)
    MedAbbr: Refuat Hashinayim
    ISSN:
    ESSN:
    IsoAbbr:
    NlmId: 227735
  • JrId: 6893
    JournalTitle: Rehabilitation literature.
    MedAbbr: Rehabil Lit
    ISSN: 0034-3579
    ESSN:
    IsoAbbr:
    NlmId: 401274
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • N16.0*
    Renal tubulo- interstitial disorders in infectious and parasitic diseases classified elsewhere
    ´Þ¸® ºÐ·ùµÈ °¨¿°¼º ¹× ±â»ýÃæ¼º Áúȯ¿¡¼­ÀÇ ¼¼´¢°ü-»çÀÌÁú¼º Àå¾Ö
  • N15.9
    Renal tubulo-interstitial disease, unspecified
    »ó¼¼ºÒ¸íÀÇ ¼¼´¢°ü-»çÀÌÁú¼º Áúȯ
  • N16.2*
    Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism
    Ç÷¾× Áúȯ ¹× ¸é¿ª ±âÀüÀ» ħ½ÀÇÑ Àå¾Ö¿¡¼­ÀÇ ¼¼´¢°ü-»çÀÌÁú¼º Àå¾Ö
  • N16*
    Renal tubulo-interstitial disorders in diseases classified elsewhere
    ´Þ¸® ºÐ·ùµÈ Áúȯ¿¡¼­ÀÇ ¼¼´¢°ü-»çÀÌÁú¼º Àå¾Ö
  • N16.3*
    Renal tubulo-interstitial disorders in metabolic diseases
    ´ë»ç Áúȯ¿¡¼­ÀÇ ¼¼´¢°ü-»çÀÌÁú¼º Àå¾Ö
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • rectal venous plexus
    Á÷ÀåÁ¤¸Æ¾ó±â, °ðâÀÚÁ¤¸Æ¾ó±â
  • rectalgia
    Á÷ÀåÅë(Áõ), °ðâÀÚÅëÁõ
  • rectangular coordinate
    Á÷°¢ÁÂÇ¥
  • rectectomy
    Á÷ÀåÀýÁ¦(¼ú), °ðâÀÚÀýÁ¦(¼ú)
  • rectification
    1. ±³Á¤ 2. Á¤·ù 3. Á¤¼ö
  • rectifier
    Á¤·ù±â
  • rectifier tube
    Á¤·ù°ü
  • rectilinear
    Á÷¼±-
  • rectilinear propagation
    Á÷Áø
  • rectitis
    Á÷Àå¿°, °ðâÀÚ¿°
  • rectoabdominal
    Á÷À庹ºÎ-, °ðâÀÚ¹è-
  • rectocele
    Á÷ÀåÅ»Ãâ, °ðâÀÚÅ»Ãâ(Áõ)
  • rectococcygeal muscle
    °ðâÀÚ²¿¸®±Ù, Á÷Àå¹Ì°ñ±Ù
  • rectococcypexy
    Á÷Àå¹Ì°ñ°íÁ¤(¼ú), °ðâÀÚ²¿¸®»À°íÁ¤(¼ú)
  • rectocolitis
    Á÷Àå°áÀå¿°, °ðâÀÚÀß·ÏâÀÚ¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • relative frequency
    »ó´ëºóµµ, ºñ±³ºóµµ
  • relative humidity
    »ó´ë½Àµµ
  • relative risk
    ºñ±³À§Çèµµ
  • relaxant
    ÀÌ¿ÏÁ¦, Ç®¸²Á¦
  • relaxation
    ÀÌ¿Ï, Ç®¸²
  • relaxation exercise
    À̿Ͽ¬½À
  • relaxation phase
    À̿ϱâ, À̿ϻó
  • relaxation rate
    À̿Ϸü
  • relaxation state
    À̿ϻóÅÂ
  • relaxation training
    ÀÌ¿ÏÈÆ·Ã
  • relaxing factor
    ÀÌ¿ÏÀÎÀÚ
  • releasing hormone
    À¯¸®È£¸£¸ó
  • relevance
    °ü·Ã¼º, ÀûÀý¼º
  • relevance index
    ģȭµµ, º´¿ø¼±È£µµ
  • reliability
    ½Å·Úµµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • recruitment phenomenon
    Á¡ÁõÇö»ó, ´©°¡Çö»ó, º¸ÃæÇö»ó
  • recrystallization
    Àç°áÁ¤
  • rectal
    °ðâÀÚ-, Á÷Àå-
  • rectal aganglionosis
    °ðâÀڽŰæÀý¾øÀ½Áõ
  • rectal ampulla
    °ðâÀÚÆØ´ë, Á÷À寨´ë
  • rectal anesthesia
    °ðâÀÚ¸¶Ãë, Á÷À帶Ãë
  • rectal application
    °ðâÀÚ³»Àû¿ë, Á÷Àå³»Àû¿ë
  • rectal artery
    °ðâÀÚµ¿¸Æ
  • rectal atresia
    °ðâÀÚÆó¼âÁõ, Á÷ÀåÆó¼âÁõ
  • rectal bleeding
    °ðâÀÚÃâÇ÷, Á÷ÀåÃâÇ÷
  • rectal crisis
    °ðâÀÚ¹ßÀÛ, Á÷Àå±ÞÅëÁõ
  • rectal dyschezia
    °ðâÀڹ躯°ï¶õ, Á÷Àå¹èº¯°ï¶õ
  • rectal fistula
    °ðâÀÚ»û±æ, Á÷Àå·ç
  • rectal hernia
    Á÷ÀåÇ츣´Ï¾Æ, °ðâÀÚÇ츣´Ï¾Æ
  • rectal incontinence
    (¢¡fecal incontinence) ´ëº¯Âñ²ûÁõ, ´ëº¯½Ç±Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • recognition
    ÀνÄ(ìããÛ).
  • recognition
    ÀÎÁö
  • recognition, self
    ÀÚ±âÀÎÁö
  • recoil atom
    ¹Ýµµ¿øÀÚ
  • recoil electron
    ¹ÝµµÀüÀÚ
  • recoil nucleus
    ¹ÝµµÇÙ
  • recoil proton
    ¹Ýµµ¾çÀÚ
  • recoil wave
    ºÒ±ÔÄ¢ÆÄ(ÝÕЮöÎ÷î).
  • recollection
    ȸ»ó, »ó±â(ßÌÑÃ)
  • recoloring
    º¹»ö(ÜÖßä).
  • recombinant
    Àç°áÇÕÀÇ
  • recombinant
    ˍ禂͟.
  • recombinant
    ÀçÁ¶ÇÕ±ÕÁÖ
  • recombinant antigen
    ÀçÁ¶ÇÕ Ç׿ø
  • recombinant DNA
    ÀçÁ¶ÇÕ DNA
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • recessive hereditary disease
    ¿­¼ºÀ¯Àüº´(¡­ë¶îîÜ»).
  • recessive heredity
    ¿­¼ºÀ¯Àü(¡­ë¶îî).
  • recessive homozygote
    ¿­¼ºÈ£¸ðÁ¢ÇÕü(¡­ïÈùêô÷).
  • recessive inheritance
    ¿­¼ºÀ¯Àü(¡­ë¶îî).
  • recessive lethals
    ¿­¼ºÄ¡»çÀÎ(¡­öÈÞÝì×).
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ(æëàõÔÍæÔܨì¶).
  • recessive trait
    ¿­¼ºÇüÁú(¡­û¡òõ).
  • recessiveness
    ¿­¼º(æëàõ).
  • recessus alveolaris ³ª
    ÀÌÆ²<Ä¡Á¶>¿À¸ñ, Ä¡Á¶µ¹±â¿Í(öÍðËÔÍÑÃèÀ).
  • recessus anterior ³ª
    ¾Õ¿À¸ñ, ÀüÇÔ¿ä (îñùèèê).
  • recessus apicis
    ¹´
  • recessus bullaris
    »ç°ñÇÔ¿ä(ÞèÍéùèèê), »ç°ñ¿Í(ÞèÍéèÀ).
  • recessus bullaris ethmoidalis ³ª
    »ç°ñ¹úÁý ¿À¸ñ, »ç°ñÆ÷ÇÔ¿ä(ÞèÍéøàùèèê).
  • recessus canmerae posterioris ³ª
    µÚ¾È¹æÇÔ¿ä, ÈľȹæÇÔ¿ä(ý­äÑÛ®ùèèê).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • repairosome
    ¸®Æä¾î·Î¼Ø
  • reparase
    ¸®Æä¾î·¹À̽º
  • repeat pipet
    ¹Ýº¹ ÆÄÀÌÆê
  • repeat unit
    ¹Ýº¹ ´ÜÀ§
  • repeated DNA sequence
    ¹Ýº¹(ÚãÜÖ)DNA ¼­¿­(ßíÖª)
  • repeated gene family
    ¹Ýº¹ À¯ÀüÀÚ °¡Á·(ë¶îîí­Ê«ðé)
  • repeating polymer
    ¹Ýº¹ ÁßÇÕü(ñìùêô÷)
  • repeating unit
    ¹Ýº¹ ´ÜÀ§(Ó¤êÈ)
  • repeats
    ¹Ýº¹Ã¼(ÚãÜÖô÷)
  • repetition frequency
    ¹Ýº¹ ºóµµ(ÞºÓø)
  • repetition number
    ¹Ýº¹ ¼ö(â¦)
  • repetitious DNA
    ¹Ýº¹ DNA
  • repetitive DNA
    ¹Ýº¹ DNA
  • repetitive gene
    ¹Ýº¹ À¯ÀüÀÚ(ë¶îîí­)
  • replacement
    ´ëÄ¡(ÓÛöÇ)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • residual urine
    ÀÜ´¢
  • resin
    ¼öÁö
  • resistance
    ÀúÇ×, ÀúÇ×¼º, ³»¼º
  • resistive electromagnet
    ÀúÇ×ÀüÀÚ¼®
  • resistive index
    ÀúÇ×Áö¼ö
  • resistive MR scanner
    ÀúÇ×ÀÚ±â°ø¸í½ºÄ³³Ê
  • resolution
    ÇØ»ó·Â, ÇØ»óµµ, ¼Ò½Ç, ¿ëÇØ, ºÐÇØ
  • resolving
    ºÐÇØÀÇ
  • resolving power
    ºÐÇØ´É, ÇØ»ó·Â
  • resonance
    °ø¸í
  • resonance condition
    °ø¸íÁ¶°Ç
  • resonance unit
    °ø¸í´ÜÀ§
  • resonant frequency
    °ø¸íÁ֯ļö
  • resonant offset angle
    °ø¸í¿ÀÇÁ¼Â°¢
  • resorption
    Èí¼ö
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • refraction
    ±¼Àý
    1. ±¼ÀýÀÇ ÀÛ¿ë ¶Ç´Â °úÁ¤. ƯÈ÷ ´«ÀÇ ±¼Àý ¿ÀÂ÷ÀÇ °áÁ¤°ú ±×°ÍÀÇ ¾È°æ¿¡ ÀÇÇÑ ±³Á¤. 2.ÇϳªÀÇ ¸Åü¿¡¼­ ¹Ðµµ°¡ ´Ù¸¥ º°°³ÀÇ ¸Åü¿¡ ºñ½ºµëÈ÷ ºûÀÌ Åë°úÇÒ ¶§ ºûÀÌ ±¸ºÎ·¯Áö´Â °Í. ÆíÇâÀº 2°³ÀÇ ¸Åü °è¸é¿¡ ÀϾ¸ç, ±¼Àý¸éÀ̶ó°í ¾Ë·ÁÁ® ÀÖ´Ù. ±¼Àý ÀüÀÇ ±¤¼±Àº ÀԻ籤, ±¼Àý ÈÄÀÇ ±¤¼±Àº ±¼Àý±¤ÀÌ´Ù. ÀԻ籤°ú ±¼Àý±¤ÀÇ ±³Â÷Á¡À» ±¼ÀýÁ¡À̶ó°í ÇÑ´Ù. ±¼ÀýÁ¡¿¡¼­ Ç¥¸é¿¡ Á÷°¢À¸·Î ±×Àº ¼±°ú ÀԻ籤°úÀÇ »çÀÌ¿¡ Çü¼ºµÈ °¢À» ÀԻ簢À̶ó°í ºÎ¸£¸ç, ±¼Àý ±¤¼±°úÀÇ »çÀÌÀÇ °¢µµ¸¦ ±¼Àý°¢À̶ó°í ºÎ¸¥´Ù. ÀԻ簢ÀÇ Á¤ÇöÀ» ±¼Àý°¢ÀÇ Á¤ÇöÀ¸·Î ³ª´« °ªÀÌ »ó´ë¼º ±¼Àý·üÀÌ´Ù
  • refractive index
    ±¼Àý·ü
  • refractive surgery
    ±¼Àý ¼ö¼ú
  • refractoriness
    ³»È­µµ, ºÒÀÀ
  • refractory cast
    ³»È­¼º ¸ðÇü
    ºÐÇØµÇÁö ¾Ê°í °í¿­À» °ßµô ¼ö ÀÖ´Â Àç·á·Î ¸¸µé¾îÁø ¸ðÇüÀ¸·Î¼­, ±¹¼Ò ÀÇÄ¡ ÁÖÁ¶¼ú¿¡ »ç¿ëµÉ ¶§ ÆØÃ¢ÇÏ¿© ±Ý¼ÓÀÇ ¼öÃàÀ» º¸»óÇÑ´Ù.
  • refractory investment
    ³»È­ ¸Å¸ôÁ¦, ³»È­¼º ¸Å¸ôÀç
    ³³ÂøÀ̳ª ÁÖÁ¶¿¡ »ç¿ëµÇ´Â °í¿Â¿¡ °ßµô¼ö ÀÖ´Â ¸Å¸ôÀç.
  • refractory mold
    ³»È­¼º ¸ôµå
  • refrigerant
    ³Ã°¢¾à, û·®Á¦
    ³Ã°¢ÇÑ ¾à°£ÀÇ À½·á¿Í Áõ¹ß¼º ·Î¼ðÀ¸·Î ÀÌ·ç¾îÁø´Ù.
  • refrigeration anesthesia
    ³Ãµ¿ ¸¶Ãë, ³Ãµ¿ ¸¶Ãë¹ý, ³Ã°¢ ¸¶Ãë
  • refrigerator
    ³ÃÀå°í
  • Refsum's disease
    ·¹ÇÁ¼¶ º´
    ÆÄÀÌź»ê
  • Refsums syndrome
    ·¾¼û ÁõÈıº
  • regaining
    ȸº¹
  • regenerated blood
    Àç»ý Ç÷¾×
  • regenerating axon
    Àç»ý Ãà»è
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
receptors, immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behaviour of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere.
(12 Dec 1998)
receptors, insulin Cell surface proteins that bind insulin and trigger intracellular changes which influence the behaviour of cells. The best understood physiological consequence of insulin receptor activation is increased transport of glucose into most cells, which controls the rate of carbohydrate metabolism. The insulin receptor is a multifunctional protein complex that has intrinsic tyrosine kinase activity and is capable of autophosphorylation.
(12 Dec 1998)
receptors, insulin-like-growth factor I Specific proteins on or in cells to which insulin-like growth factor I (somatomedin c) binds and thereby modifies the function of the cells. These receptors contain transmembrane and cytosolic domains, bind igf-I preferentially, and have high-affinity sites for igf-II. The alpha-subunit has a mw of 130 kD and the beta subunit possesses tyrosine kinase activity.
(12 Dec 1998)
receptors, insulin-like-growth-factor II Specific proteins on or in cells to which insulin-like growth factor II and mannose-6-phosphate bind and thereby modify the function of the cells. These receptors have a mw of 250 kD and possess no tyrosine kinase activity.
(12 Dec 1998)
receptors, interferon Specific molecular sites or structures on or in cells with which interferons react or to which they bind in order to modify the function of the cells. Interferons exert their pleiotropic effects through two different receptors. Alpha- and beta-interferon crossreact with common receptors, while gamma-interferon initiates its biological effects through its own specific receptor system.
(12 Dec 1998)
receptors, interleukin Cell surface proteins that bind interleukins and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
receptors, interleukin-1 Specific molecular sites or structures on cells with which interleukin-1 reacts or to which it binds to modify the function of the cells. The il-1 receptor on T-lymphocytes and fibroblasts is composed of a single polypeptide chain that binds both il-1 alpha and il-1 beta. The molecular weight of this high-affinity receptor is believed to be 80 kD.
(12 Dec 1998)
receptors, interleukin-2 Receptors present on activated t- and B-cells as a complex consisting of a 55 kD peptide, which reacts with the anti-tac monoclonal antibody, and a 75 kD non-tac interleukin-2-binding peptide. The receptor is present in two forms, one with a very high affinity and the other with low affinity for il-2. The high-affinity form appears to mediate exclusively the growth-promoting response to il-2. The receptor is present in large numbers on resting HTLV-I leukaemia cells, but not on normal resting cells.
(12 Dec 1998)
receptors, interleukin-3 Phosphotyrosine-containing proteins, mw 140 kD. They form a stable complex with interleukin-3 with an apparent mass of 170 kD. They are found on a variety of cells and activate interleukin-3.
(12 Dec 1998)
receptors, interleukin-4 Receptors present on a wide variety of haematopoietic and non-haematopoietic cell types and various human tumours. Two forms of the receptor have been described, soluble and membrane-bound. Low affinity and high affinity receptors for il-4 have been reported.
(12 Dec 1998)
receptors, interleukin-6 <chemical> Receptors present on t cells, mitogen-activated B-cells, peripheral monocytes, and some macrophage- and B-cell-derived tumour cell types. The receptor is a strongly glycosylated protein of 80 kD and a length of 468 amino acids.
Pharmacological action: growth inhibitors.
(12 Dec 1998)
receptors, invertebrate peptide Cell surface receptors for invertebrate peptide hormones or neuropeptides.
(12 Dec 1998)
receptors, kainic acid Cell surface proteins that bind glutamate and directly gate ion channels. Kainic acid receptors were originally discriminated from other glutamate receptors by their affinity for the agonist kainic acid. Activation of kainic acid receptors is generally excitatory to cells. Subtypes have been cloned, and for some the traditional distinction from ampa receptors may not apply.
(12 Dec 1998)
receptors, laminin Glycoprotein molecules on the surface of cells that react with or bind to laminin whose function allows the binding of epithelial cells to the basement membrane. The molecular weight of this high-affinity receptor is 67 kD.
(12 Dec 1998)
receptors, ldl Receptors on the plasma membrane of nonhepatic cells that specifically bind ldl. The receptors are localised in specialised regions called coated pits. Hypercholesteraemia is caused by an allelic genetic defect of three types: 1) receptors do not bind to ldl; 2) there is reduced binding of ldl; and 3) there is normal binding but no internalization of ldl. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 15
  • Receptor, Muscarinic M1 - »õâ A specific subtype of muscarinic receptor that has a high affinity for the drug PIRENZEPINE. It is found in the peripheral GANGLIA where it signals a variety of physiological functions such as GASTRIC ACID secretion and BRONCHOCONSTRICTION. This subtype of muscarinic receptor is also found in neuronal tissues including the CEREBRAL CORTEX and HIPPOCAMPUS where it mediates the process of MEMORY and LEARNING.
    Synonyms : Muscarinic Receptors M1, Receptors, Muscarinic M1, M1 Receptor, Muscarinic, M1 Receptors, Muscarinic, M1, Muscarinic Receptor, M1, Muscarinic Receptors, Muscarinic M1 Receptor, Muscarinic M1 Receptors, Receptor M1, Muscarinic, Receptors M1, Muscarinic
  • Receptor, Muscarinic M2 - »õâ A specific subtype of muscarinic receptor found in the lower BRAIN, the HEART and in SMOOTH MUSCLE-containing organs. Although present in smooth muscle the M2 muscarinic receptor appears not to be involved in contractile responses.
    Synonyms : Muscarinic Receptors M2, Receptors, Muscarinic M2, M2 Receptor, Muscarinic, M2 Receptors, Muscarinic, M2, Muscarinic Receptor, M2, Muscarinic Receptors, Muscarinic M2 Receptor, Muscarinic M2 Receptors, Receptor M2, Muscarinic, Receptors M2, Muscarinic
  • Receptor, Muscarinic M3 - »õâ A subclass of muscarinic receptor that mediates cholinergic-induced contraction in a variety of SMOOTH MUSCLES.
    Synonyms : Muscarinic Receptors M3, Receptors, Muscarinic M3, M3 Receptor, Muscarinic, M3 Receptors, Muscarinic, M3, Muscarinic Receptor, M3, Muscarinic Receptors, Muscarinic M3 Receptor, Muscarinic M3 Receptors, Receptor M3, Muscarinic, Receptors M3, Muscarinic
  • Receptor, Muscarinic M4 - »õâ A specific subtype of muscarinic receptor found in the CORPUS STRIATUM and the LUNG. It has similar receptor binding specificities to MUSCARINIC RECEPTOR M1 and MUSCARINIC RECEPTOR M2.
    Synonyms : M4 Receptor, Muscarinic, M4 Receptors, Muscarinic, M4, Muscarinic Receptor, M4, Muscarinic Receptors, Muscarinic M4 Receptor, Muscarinic M4 Receptors, Receptor M4, Muscarinic, Receptors M4, Muscarinic
  • Receptor, Muscarinic M5 - »õâ A specific subtype of muscarinic receptor found in a variety of locations including the SALIVARY GLANDS and the SUBSTANTIA NIGRA and VENTRAL TEGMENTAL AREA of the BRAIN.
    Synonyms : M5 Muscarinic Receptor, Receptors, Muscarinic M5, M5 Receptor, Muscarinic, M5 Receptors, Muscarinic, M5, Muscarinic Receptor, M5, Muscarinic Receptors, Muscarinic M5 Receptor, Muscarinic M5 Receptors, Muscarinic Receptor, M5, Receptor M5, Muscarinic
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
·¹¾ÆÆä·ÐÁÖ1000¸¸IU - »õâ
µ¿½ÅÁ¦¾à
A15106921 Interferon Alpha-2b
Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ
·¹¹ÌÄÚÆ®¼­¹æ¼ºÄ°¼¿2mg - »õâ
ÄÚ¿À·ÕÁ¦¾à
A04703961 Emedastine Difumarate
Àü¹®ÀǾàǰ | ±Þ¿©
·¹¹ÌÄÉÀ̵åÁÖ100mg - »õâ
Schering-Plough
E04060351 Infliximab
Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ
³ëº¸³ÑÁ¤1mg - »õâ
Novo Nordisk
E08720201 Repaglinide
Àü¹®ÀǾàǰ | ±Þ¿©
³ëº¸³ÑÁ¤2mg - »õâ
Novo Nordisk
E08720191 Repaglinide
Àü¹®ÀǾàǰ | ±Þ¿©
·¹³ë¸»Á¤ - »õâ
ÅÂÆò¾çÁ¦¾à
A02350191 Aluminum hydroxide gel(dried), Magnesium Carbonate
ÀϹÝÀǾàǰ | »èÁ¦
·º½ºÆÄÁÖ - »õâ
»ïõ´çÁ¦¾à
A08451141 Gallamine triethiodide
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
¸®Ä¡Ä®½·¿¬Áúݼ¿ - »õâ
½ÅÀÏÁ¦¾à
A20751931 Alfacalcidol
ÀϹÝÀǾàǰ | ±Þ¿©
·¹¹Ù¹ÌµåÁ¤ - »õâ
°æµ¿Á¦¾à
A17603721 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
¸®¿µÁ¤ - »õâ
½ì¶óÆ®ÆÊÄÚ¸®¾Æ
Extr. Damianae fol. Sicc, Extr. Muira puama lign. Sicc, Extr. Yohimbe Cort. Sicc, Fol. Damianae pulv, Lecithin, Lign. Muira puama pulv
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
recrudescence a return of something after a period of abatement; "a recrudescence of racism"; "a recrudescence of the symptoms"
Ãâó: wordnet.princeton.edu/perl/webwn
retinol vitamin A1: an unsaturated alcohol that occurs in marine fish-liver oils and is synthesized biologically from carotene
Ãâó: wordnet.princeton.edu/perl/webwn
reporting coverage: the news as presented by reporters for newspapers or radio or television; "they accused the paper of biased coverage of race relations"
Ãâó: wordnet.princeton.edu/perl/webwn
reflective brooding: persistently or morbidly thoughtful capable of physically reflecting light or sound; "a reflective surface" devoted to matters of the mind; "the reflective type"
Ãâó: wordnet.princeton.edu/perl/webwn
rectal reflex defecation reflex: normal response to the presence of feces in the rectum
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • reaping machine
    ÀÚµ¿ ¼öÈ®±â
  • reapparel
    (¿ÊÀ»)´Ù½Ã ÀÔÈ÷´Ù;»õ·Î ÀÔÈ÷´Ù
  • reappear
    ´Ù½Ã ³ªÅ¸³ª´Ù
  • reappear
    ÀçÇö(Àç¹ß)ÇÏ´Ù
  • reappearance
    ÀçÇö;Àç¹ß
  • reapperarance
    ÀçÇö
  • reapplication
    ÀçÀû¿ë;Àç½Åû;ÀçÁö¿ø È÷
  • reapply
    ´Ù½Ã »ç¿ëÇÏ´Ù;´Ù½Ã Àû¿ëÇÏ´Ù;´Ù½Ã Á¾»ç½ÃŰ´Ù;Àç½Åû(ÀçÁö¿ø)ÇÏ´Ù
  • reappoint
    ´Ù½Ã ÀÓ¸íÇÏ´Ù
  • reappoint
    ´Ù½Ã ÀÓ¸í(ÁöÁ¤)ÇÏ´Ù;º¹Á÷(Àç¼±)½ÃŰ´Ù;~ment
  • reapportion
    ...À» ´Ù½Ã ¹èºÐ(ÇÒ´ç)ÇÏ´Ù;(¼±°Å±¸ ÀÇ¿ø¼ö¸¦)Àç¹èºÐÇÏ´Ù;Àç¹èºÐÇÏ´Ù;~ment
  • reappraisal
    ÀçÆò°¡;Àç°ËÅä
  • reappraise
    ´Ù½Ã Æò°¡ÇÏ´Ù;Àç°ËÅäÇÏ´Ù
  • rear
    µÚ
  • rear
    µÚ;¹èÈÄ;(¸Ç)ÈĺÎ;ÈÄÀ§;ÈĹÌ;(³²ÀÚ¿ë)º¯¼Ò;±ÃµÕÀÌ(buttocks);ÈĹæÀÇ;ÈĹ濡¼­(À¸·Î);µÚº¸·¯ °¡´Ù;º¯¼Ò¿¡ °¡´Ù;(³ôÀº °Ç¹°À»)¼¼¿ì´Ù;°Ç¸³ÇÏ´Ù;(¹°°ÇÀ»)¶È¹Ù·Î ¼¼¿ì´Ù;ÀÏÀ¸Å°´Ù;µé¾î¿Ã¸®´Ù;±â¸£´Ù;»çÀ°ÇÏ´Ù;Àç¹èÇÏ´Ù;±æµéÀÌ´Ù;³ôÀÌ´Ù;¼Ú°Ô ÇÏ´Ù;(¸» µîÀÌ)µÞ´Ù¸®·Î ¼­´Ù;(»ç¶÷ÀÌ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 15
RE made for purchase and immediate use
RE commercially produced
RE repeated regularly without thought or originality
RE a commercial preparation containing most of the ingredients for a dish
RE (of clothing) made in standard sizes
RE the activity of putting or setting in order in advance of some act or purpose
RE affiliation anew
RE affirm once again
RE renewed affirmation
RE 40th President of the United States (1911-)
RE the executive under President Reagan
RE a chemical agent for use in chemical reactions
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 15
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
ÅëÇÕ°Ë»ö ¿Ï·á